AU2003223208A8 - Mp21s as modifiers of the p21 pathway and methods of use - Google Patents

Mp21s as modifiers of the p21 pathway and methods of use

Info

Publication number
AU2003223208A8
AU2003223208A8 AU2003223208A AU2003223208A AU2003223208A8 AU 2003223208 A8 AU2003223208 A8 AU 2003223208A8 AU 2003223208 A AU2003223208 A AU 2003223208A AU 2003223208 A AU2003223208 A AU 2003223208A AU 2003223208 A8 AU2003223208 A8 AU 2003223208A8
Authority
AU
Australia
Prior art keywords
mp21s
modifiers
pathway
methods
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2003223208A
Other versions
AU2003223208A1 (en
Inventor
Lori Friedman
Timothy S Heuer
Marcia Belvin
Gregory D Plowman
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Exelixis Inc
Original Assignee
Exelixis Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Exelixis Inc filed Critical Exelixis Inc
Publication of AU2003223208A8 publication Critical patent/AU2003223208A8/en
Publication of AU2003223208A1 publication Critical patent/AU2003223208A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4702—Regulators; Modulating activity

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
AU2003223208A 2002-03-01 2003-02-28 MP21s AS MODIFIERS OF THE p21 PATHWAY AND METHODS OF USE Abandoned AU2003223208A1 (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US36075902P 2002-03-01 2002-03-01
US36082502P 2002-03-01 2002-03-01
US60/360,825 2002-03-01
US60/360,759 2002-03-01
PCT/US2003/006088 WO2003074663A2 (en) 2002-03-01 2003-02-28 MP21s AS MODIFIERS OF THE p21 PATHWAY AND METHODS OF USE

Publications (2)

Publication Number Publication Date
AU2003223208A8 true AU2003223208A8 (en) 2003-09-16
AU2003223208A1 AU2003223208A1 (en) 2003-09-16

Family

ID=27791653

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2003223208A Abandoned AU2003223208A1 (en) 2002-03-01 2003-02-28 MP21s AS MODIFIERS OF THE p21 PATHWAY AND METHODS OF USE

Country Status (2)

Country Link
AU (1) AU2003223208A1 (en)
WO (1) WO2003074663A2 (en)

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5958697A (en) * 1997-12-08 1999-09-28 Tularik Inc. Isolated nucleic acids encoding CYP7 promoter-binding factors

Also Published As

Publication number Publication date
WO2003074663A2 (en) 2003-09-12
WO2003074663A3 (en) 2004-03-25
AU2003223208A1 (en) 2003-09-16

Similar Documents

Publication Publication Date Title
AU2003216482A8 (en) Msras as modifiers of the p53 pathway and methods of use
EP1651956A4 (en) Melks as modifiers of the rac pathway and methods of use
AU2003272390A8 (en) Ampds as modifiers of the p21 pathway and methods of use
EP1535067A4 (en) PAPSSs AS MODIFIERS OF THE AXIN PATHWAY AND METHODS OF USE
AU2003251826A8 (en) Mp21s as modifiers of the p21 pathway and methods of use
EP1534852A4 (en) CSNK1GS AS MODIFIERS OF THE p21 PATHWAY AND METHODS OF USE
AU2003265263A1 (en) ADCY3S AS MODIFIERS OF THE p21 PATHWAY AND METHODS OF USE
AU2003251799A1 (en) Mchks as modifiers of the chk1 pathway and methods of use
AU2003223208A8 (en) Mp21s as modifiers of the p21 pathway and methods of use
AU2003274911A8 (en) Mrbs as modifiers of the rb pathway and methods of use
AU2003303094A8 (en) Mat2as as modifiers of the p53 pathway and methods of use
EP1412477A4 (en) GPCs AS MODIFIERS OF THE IRRTK AND P21 PATHWAYS AND METHODS OF USE
AU2003263993A8 (en) Mp2153s as modifiers of the p21 or p53 pathway and methods of use
AU2003294499A8 (en) Rhebs as modifiers of the rb pathway and methods of use
EP1578945A3 (en) Cct6s as modifiers of the rb pathway and methods of use
EP1540333A4 (en) Maxs as modifiers of the axin pathway and methods of use
AU2003213693A8 (en) Mchks as modifiers of the chk pathway and methods of use
AU2003213665A8 (en) Lgals as modifiers of the chk pathway and methods of use
AU2003299990A8 (en) Mbcats as modifiers of the beta-catenin pathway and methods of use
AU2003217851A8 (en) Mbcats as modifiers of the beta-catenin pathway and methods of use
AU2003278811A8 (en) Ldlrs as modifiers of the p53 pathway and methods of use
EP1587910A4 (en) Facls as modifiers of the rb pathway and methods of use
EP1687405A4 (en) Ttbks as modifiers of the beta catenin pathway and methods of use
EP1633852A4 (en) Sppls as modifiers of the p53 pathway and methods of use
AU2003213662A8 (en) Mbcats as modifiers of the beta-catenin pathway and methods of use

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase